{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T20:45:26Z","timestamp":1696020326756},"reference-count":14,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jtim-2016-0006_s_001_w2aab3b8c11b1b7b1aab1c13b1Aa\">\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To assess the anticoagulant therapy for non-ST-segment elevation acute coronary syndrome (NSTE-ACS) in China and to offer the rationale for establishing reasonable strategies to improve the prognosis of NSTE-ACS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jtim-2016-0006_s_002_w2aab3b8c11b1b7b1aab1c13b2Aa\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 1,502 patients with NSTE-ACS were recruited from 28 third-grade hospitals distributed in 14 provinces and cities in China from December 2009 to December 2011. The strategies for diagnosis and treatment, decided by each hospital respectively, were used for further analysis and comparison of medication, percutaneous coronary intervention (PCI), and end points for efficacy and safety assessment at 9 and 30 days following PCI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jtim-2016-0006_s_003_w2aab3b8c11b1b7b1aab1c13b3Aa\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A lower incidence rate (<jats:italic>P<\/jats:italic> &lt; 0.05) was noted for efficacy and safety in patients with unstable angina (UA) than those with non-ST-segment elevation myocardial infarction (NSTE-MI). The prescription rate of unfractionated heparin (UFH), low-molecular-weight heparin (LMWH), fondaparinux, PCI, and single medication was 0.61%, 66.42%, 30.61%, 69.64%, and 70.74%, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jtim-2016-0006_s_004_w2aab3b8c11b1b7b1aab1c13b4Aa\">\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Compared with NSTE-MI, UA is featured with better prognosis, less severity, and different outcome. However, in clinical practice, the therapies for NSTE-MI and UA show no differences, which deserves great attention. In China, the most common anticoagulant therapies for NSTE-ACS are single medication, mainly based on LMWH and PCI.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jtim-2016-0006","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T10:22:28Z","timestamp":1480933348000},"page":"25-28","source":"Crossref","is-referenced-by-count":2,"title":["Anticoagulant therapy for non-ST-segment elevation acute coronary syndrome in China: A multi-center observational study"],"prefix":"10.1515","volume":"4","author":[{"given":"Xiao-huan","family":"Gong","sequence":"first","affiliation":[{"name":"Key Laboratory of Public Health Safety, Ministry of Education, Centre for Clinical Epidemiology, School of Public Health, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-ming","family":"Yu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Public Health Safety, Ministry of Education, Centre for Clinical Epidemiology, School of Public Health, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Mao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Public Health Safety, Ministry of Education, Centre for Clinical Epidemiology, School of Public Health, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-yi","family":"Hu","sequence":"additional","affiliation":[{"name":"Heart Center, Peking University People\u2019s Hospital, Peking 100044, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"2023042508075890249_j_jtim-2016-0006_ref_001_w2aab3b8c11b1b7b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Wright RS, Anderson JL, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, et al. 2011 ACCF\/AHA Focused Update Incorporated Into the ACC\/ AHA 2007 Guidelines for the Management of Patients With Unstable Angina\/Non\u2013ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 57: e215-e367.","DOI":"10.1016\/j.jacc.2011.02.011"},{"key":"2023042508075890249_j_jtim-2016-0006_ref_002_w2aab3b8c11b1b7b1ab2b1b2Aa","unstructured":"Hu DY, Jia SQ, Wang JY. Acute Coronary Syndromes. [Translated from Acute Coronary Syndromes, Th\u00e9roux P]. Peking: People\u2019s Medical Publishing House, 2007: 9."},{"key":"2023042508075890249_j_jtim-2016-0006_ref_003_w2aab3b8c11b1b7b1ab2b1b3Aa","unstructured":"Song L, Yan HB. Application of fondaparinux in the treatment of acute coronary syndrome. Chin J Cardiol 2010; 38: 472-4."},{"key":"2023042508075890249_j_jtim-2016-0006_ref_004_w2aab3b8c11b1b7b1ab2b1b4Aa","unstructured":"Ma AQ, Hu DY. Cardiology. Peking: People\u2019s Medical Publishing House, 2005:304."},{"key":"2023042508075890249_j_jtim-2016-0006_ref_005_w2aab3b8c11b1b7b1ab2b1b5Aa","unstructured":"Chinese Society of Cardiology, editorial board of Chinese Journal of Cardiology. Diagnostic and therapeutic guidelines for the management of patients with unstable angina\/non\u2013ST-elevation myocardial infarction. Chin J Cardiol 2007; 35: 295-304."},{"key":"2023042508075890249_j_jtim-2016-0006_ref_006_w2aab3b8c11b1b7b1ab2b1b6Aa","unstructured":"Han YL. Individualized therapy \u2013 an orientation for the antithrombus therapy for coronary heart diseases. Med J Chin PLA 2008; 33: 921-2."},{"key":"2023042508075890249_j_jtim-2016-0006_ref_007_w2aab3b8c11b1b7b1ab2b1b7Aa","unstructured":"Shi XB. The anticoagulant therapy 2008. Paper collections from The 10th South China International Congress of Cardiology, Guangzhou, 2008."},{"key":"2023042508075890249_j_jtim-2016-0006_ref_008_w2aab3b8c11b1b7b1ab2b1b8Aa","unstructured":"Zhai ZG, Wang C, Liu YM, Qin ZQ. Comparison of unfractionated heparin and low molecular weight heparin in pulmonary thromboembolism: meta-analysis. Acta Acad Med Sin 2004; 26: 221-6."},{"key":"2023042508075890249_j_jtim-2016-0006_ref_009_w2aab3b8c11b1b7b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"de Lemos JA, Blazing MA, Wiviott SD, Brady WE, White HD, Fox KA, et al. Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: Results from the A phase of the A-to-Z trial. Eur Heart J 2004; 25: 1688-94.","DOI":"10.1016\/j.ehj.2004.06.028"},{"key":"2023042508075890249_j_jtim-2016-0006_ref_010_w2aab3b8c11b1b7b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Simoons ML, Bobbink IW, Boland J, Gardien M, Klootwijk P, Lensing AW, et al. A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the pentasaccharide in unstable angina (PENTUA) study. J Am Coll Cardiol 2004; 43: 2183-90.","DOI":"10.1016\/j.jacc.2004.02.051"},{"key":"2023042508075890249_j_jtim-2016-0006_ref_011_w2aab3b8c11b1b7b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, et al. Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators, Yusuf S, Mehta SR, et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006; 354: 1464-76.","DOI":"10.1056\/NEJMoa055443"},{"key":"2023042508075890249_j_jtim-2016-0006_ref_012_w2aab3b8c11b1b7b1ab2b1c12Aa","unstructured":"Hu DY, Huo Y, Ma CS. Diagnostic and therapeutic guidelines for cardiovascular diseases. Peking: People\u2019s Medical Publishing House, 2009: 229."},{"key":"2023042508075890249_j_jtim-2016-0006_ref_013_w2aab3b8c11b1b7b1ab2b1c13Aa","unstructured":"Lv SZ. Optimal therapeutic strategy in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). China Medical Herald 2010; 7: 5."},{"key":"2023042508075890249_j_jtim-2016-0006_ref_014_w2aab3b8c11b1b7b1ab2b1c14Aa","unstructured":"Multi-central Collaborative Group on Chinese Registry of Acute Coronary Events. Comparison of current clinical practice and guideline application in therapies of ACS: findings from the Multi-central Collaborative Group on Chinese Registry of Acute Coronary Events. Chin J Cardiol 2005; 33: 789-92."}],"container-title":["Journal of Translational Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/jtim\/4\/1\/article-p25.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jtim-2016-0006\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jtim-2016-0006\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T08:11:49Z","timestamp":1682410309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jtim-2016-0006\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,1]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,14]]},"published-print":{"date-parts":[[2016,4,1]]}},"alternative-id":["10.1515\/jtim-2016-0006"],"URL":"https:\/\/doi.org\/10.1515\/jtim-2016-0006","relation":{},"ISSN":["2224-4018"],"issn-type":[{"value":"2224-4018","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,1]]}}}